|
Gene Name |
Aligned on chrom |
Cyto location |
Supporting cDNA clones |
Description |
1 | ADRB2 | 5 | "5q31-q32" | 125 | adrenergic, beta-2-, receptor, surface. |
2 | ALX4 | 11 | "11p11.2" | 15 | ALX homeobox 4. |
3 | AMPD1andDENND2CandBCAS2 | 1 | "1p13.2" | 566 | adenosine monophosphate deaminase 1 and breast carcinoma amplified sequence 2. |
4 | ANKMY2 | 7 | "7p21" | 272 | ankyrin repeat containing protein and MYND finger containing protein. |
5 | APCandSRP19andZRSR1 | 5 | "5q22" | 685 | adenomatous polyposis coli and signal recognition particle 19kDa and zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 1. |
6 | APOE | 19 | "19q13.2" | 266 | apolipoprotein E. |
7 | ARHGAP5 | 14 | "14q12" | 438 | Rho GTPase activating protein 5. |
8 | ARHGEF17 | 11 | "11q13.4" | 214 | Rho guanine nucleotide exchange factor (GEF) 17. |
9 | ARMS2 | 10 | "10q26.13" | 22 | age-related maculopathy susceptibility 2. |
10 | ARVCF | 22 | "22q11.21" | 192 | armadillo repeat gene deleted in velocardiofacial syndrome. |
11 | ASTN2 | 9 | "9q33.1" | 238 | astrotactin 2. |
12 | AUP1 | 2 | "2p13" | 488 | ancient ubiquitous protein 1. |
13 | BEND2 | X | "Xp22.13" | 12 | |
14 | BRCA1P1 | 17 | "17q21" | 306 | breast cancer 1, early onset and BRCA1 pseudogene 1. |
15 | BVES | 6 | "6q21" | 92 | blood vessel epicardial substance. |
16 | C7orf58 | 7 | "7q31.31" | 169 | protein CRA b family member. |
17 | C12orf5 | 12 | "12p13.3" | 172 | probable fructose-2 6-bisphosphatase tigar. |
18 | CAND2 | 3 | "3p25.2" | 88 | cullin-associated and neddylation-dissociated 2 (putative). |
19 | CCND1 | 11 | "11q13" | 296 | cyclin D1. |
20 | CCND2 | 12 | "12p13" | 485 | cyclin D2. |
21 | CCND2P | 11 | "11q13" | 1 | cyclin D2 pseudogene. |
22 | CCND3 | 6 | "6p21" | 622 | cyclin D3. |
23 | CCNE1 | 19 | "19q12" | 107 | cyclin E1. |
24 | CCT5 | 5 | "5p15.2" | 576 | chaperonin containing TCP1, subunit 5 (epsilon). |
25 | CDH1 | 16 | "16q22.1" | 419 | cadherin 1, type 1, E-cadherin (epithelial). |
26 | CDH13 | 16 | "16q23.3" | 493 | cadherin 13, H-cadherin (heart). |
27 | CDK2 | 12 | "12q13" | 400 | cyclin-dependent kinase 2. |
28 | CDK4 | 12 | "12q14" | 326 | cyclin-dependent kinase 4. |
29 | CDK6 | 7 | "7q21-q22" | 614 | cyclin-dependent kinase 6. |
30 | CDKN1A | 6 | "6p21.2" | 582 | cyclin-dependent kinase inhibitor 1A (p21, Cip1). |
31 | CDKN1B | 12 | "12p13.1-p12" | 595 | cyclin-dependent kinase inhibitor 1B (p27, Kip1). |
32 | CDKN2A | 9 | "9p21" | 237 | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4). |
33 | CDKN2B | 9 | "9p21" | 158 | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4). |
34 | CDKN2C | 1 | "1p32" | 306 | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4). |
35 | CDKN2D | 19 | "19p13" | 166 | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4). |
36 | CENPB | 20 | "20p13" | 298 | centromere protein B, 80kDa. |
37 | CFH | 1 | "1q32" | 558 | complement factor H. |
38 | CLCNKA | 1 | "1p36" | 78 | chloride channel Ka. |
39 | CLCNKB | 1 | "1p36" | 84 | chloride channel Kb. |
40 | CLDND2andETFB | 19 | "19q13.41" | 427 | electron-transfer-flavoprotein, beta polypeptide. |
41 | COPS5andLRRC67 | 8 | "8q13.1" | 401 | COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis) and leucine rich repeat containing 67. |
42 | CREBBP | 16 | "16p13.3" | 500 | CREB binding protein. |
43 | CTNNB1 | 3 | "3p21" | 450 | catenin (cadherin-associated protein), beta 1, 88kDa. |
44 | CTNND2 | 5 | "5p15.2" | 424 | catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein). |
45 | DAPK1 | 9 | "9q34.1" | 344 | death-associated protein kinase 1. |
46 | DCTN1 | 2 | "2p13" | 805 | dynactin 1. |
47 | DENND2A | 7 | "7q34" | 135 | DENN 2A family member. |
48 | DENND2D | 1 | "1p13.3" | 356 | uDENN domain containing protein and DENN (AEX-3) domain containing protein and dDENN domain containing protein family member. |
49 | EGLN1 | 1 | "1q42.1" | 394 | egl nine homolog 1 family member. |
50 | EP300 | 22 | "22q13.2" | 387 | E1A binding protein p300. |
51 | ERBB2 | 17 | "17q11.2-q12|17q21.1" | 476 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian). |
52 | ESR1 | 6 | "6q25.1" | 196 | estrogen receptor 1. |
53 | F2 | 11 | "11p11" | 277 | coagulation factor II (thrombin). |
54 | F5 | 1 | "1q23" | 385 | coagulation factor V (proaccelerin, labile factor). |
55 | FAN1 | 15 | "15q13.2-q13.3" | 242 | FANCD2/FANCI-associated nuclease 1. |
56 | FBLIM1 | 1 | "1p36.21" | 294 | filamin binding LIM protein 1. |
57 | FERMT1 | 20 | "20p12.3" | 161 | fermitin family member 1. |
58 | FERMT2 | 14 | "14q22.1" | 365 | fermitin family member 2. |
59 | FERMT3 | 11 | "11q13.1" | 339 | fermitin family member 3. |
60 | FGFR3 | 4 | "4p16.3" | 75 | fibroblast growth factor receptor 3. |
61 | FN1 | 2 | "2q34" | 920 | fibronectin 1. |
62 | FNBP1 | 9 | "9q34" | 444 | formin binding protein 1. |
63 | GAD1 | 2 | "2q31" | 437 | glutamate decarboxylase 1 (brain, 67kDa). |
64 | GATA4 | 8 | "8p23.1-p22" | 163 | GATA binding protein 4. |
65 | GREM1 | 15 | "15q13.3" | 605 | gremlin 1. |
66 | GRIN1 | 9 | "9q34.3" | 101 | glutamate receptor, ionotropic, N-methyl D-aspartate 1. |
67 | HAND1 | 5 | "5q33" | 58 | heart and neural crest derivatives expressed 1. |
68 | HAND2 | 4 | "4q33" | 67 | heart and neural crest derivatives expressed 2. |
69 | HDAC2 | 6 | "6q21" | 461 | histone deacetylase 2. |
70 | HDAC3 | 5 | "5q31" | 347 | histone deacetylase 3. |
71 | HEY1 | 8 | "8q21" | 289 | hairy/enhancer-of-split related with YRPW motif 1. |
72 | HEY2 | 6 | "6q21" | 75 | hairy/enhancer-of-split related with YRPW motif 2. |
73 | HIF1AandSNAPC1 | 14 | "14q22" | 441 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) and small nuclear RNA activating complex, polypeptide 1, 43kDa. |
74 | HMGA1 | 6 | "6p21" | 926 | high mobility group AT-hook 1. |
75 | HOXD13 | 2 | "2q31.1" | 13 | homeobox D13. |
76 | HTRA2 | 2 | "2p12" | 314 | HtrA serine peptidase 2. |
77 | IHH | 2 | "2q33-q35" | 53 | Indian hedgehog. |
78 | IRX1 | 5 | "5p15.3" | 38 | iroquois homeobox 1. |
79 | IRX2 | 5 | "5p15.33" | 188 | iroquois homeobox 2. |
80 | JAK2 | 9 | "9p24" | 115 | Janus kinase 2. |
81 | KCNA2 | 1 | "1p13" | 40 | potassium voltage-gated channel, shaker-related subfamily, member 2. |
82 | KCNA4 | 11 | "11p14" | 48 | potassium voltage-gated channel, shaker-related subfamily, member 4. |
83 | KCND1 | X | "Xp11.23" | 42 | potassium voltage-gated channel, Shal-related subfamily, member 1. |
84 | KCND2 | 7 | "7q31" | 66 | potassium voltage-gated channel, Shal-related subfamily, member 2. |
85 | KCND3 | 1 | "1p13.3" | 45 | potassium voltage-gated channel, Shal-related subfamily, member 3. |
86 | KCNH2 | 7 | "7q36.1" | 166 | potassium voltage-gated channel, subfamily H (eag-related), member 2. |
87 | KCNH5 | 14 | "14q23.1" | 24 | potassium voltage-gated channel, subfamily H (eag-related), member 5. |
88 | KCNQ1 | 11 | "11p15.5" | 146 | potassium voltage-gated channel, KQT-like subfamily, member 1. |
89 | LMO2 | 11 | "11p13" | 219 | LIM domain only 2 (rhombotin-like 1). |
90 | MEF2A | 15 | "15q26" | 448 | myocyte enhancer factor 2A. |
91 | MEF2C | 5 | "5q14" | 449 | myocyte enhancer factor 2C. |
92 | MEF2D | 1 | "1q12-q23" | 411 | myocyte enhancer factor 2D. |
93 | MGMT | 10 | "10q26" | 180 | O-6-methylguanine-DNA methyltransferase. |
94 | MON1B | 16 | "16q23.1" | 554 | MON1 homolog B (yeast). |
95 | MSI1 | 12 | "12q24" | 45 | musashi homolog 1 (Drosophila). |
96 | MTHFR | 1 | "1p36.3" | 185 | methylenetetrahydrofolate reductase (NAD(P)H). |
97 | MUC5ACandMUC5B | 11 | "11p15.5" | 292 | mucin 5AC, oligomeric mucus/gel-forming and mucin 5B, oligomeric mucus/gel-forming. |
98 | MUC6 | 11 | "11p15.5" | 121 | mucin 6, oligomeric mucus/gel-forming. |
99 | MYCN | 2 | "2p24.1" | 259 | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian). |
100 | MYT1L | 2 | "2p25.3" | 164 | myelin transcription factor 1-like. |